News Alert: GE Healthcare recalls certain SpO2 sensors due to risk of errors during defibrillation | Cardiovascular Business

Home

Recent Newsletters

FDA approves next-gen HF device | Inconsistent radiation doses | Treating ‘no-option’ patients | New GLP-1 data | CHD risks

Week in Review: FDA's alert about J&J heart pumps | $71M in fraud | A new obstacle for heart patients | Lead approved for LBBAP

The long-term impact of hypertension during pregnancy | Heart disease, stroke on the rise among women | CCTA delivers value

Vascular imaging at heart of $71M fraud scheme | Planning before TAVR | FDA clears platform | Whole-body MRI provider adds CCTA

It’s getting harder for heart patients to seek help | New PE guidelines | What cardiologists need to know about Lp(a)

FDA shares heart pump warning | Women face rising cardiovascular risks | Alcohol use & CLTI outcomes | 20-year PFO closure data

Reprocessed medical devices recalled | CGM sensor issue linked to 860 serious injuries | Managing patients with high-risk leads

Design by Adaptive Theme